Lexpos News

The Department of Health and Social Care (DHSC) has today (30/04/2026) confirmed the following list of price concessions for April 2026. Community Pharmacy England has issued a statement in response: Record concession numbers indicative of volatility in supply chain, warns CPE. This list for April 2026 includes twelve further price concessions and improved prices for [...]

The post April 2026 Price Concessions 5th update including improved prices appeared first on Community Pharmacy England.

Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse. There have been reports of worsening nasal congestion (rebound congestion) when the effects of nasal decongestant sprays or drops containing xylometazoline hydrochloride and oxymetazoline hydrochloride, referred to hereafter as ‘xylometazoline’ and ‘oxymetazoline’, wear [...]

The post MHRA Drug Safety Update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride appeared first on Community Pharmacy England.

The mid-term election for an ‘Independent regional representative’ for Community Pharmacy England’s East and North Midlands region begins next week. This follows Lindsey Fairbrother’s resignation from the Committee. Eligible pharmacists* who are Independent pharmacy owners and members or officers of one of the LPCs in the region are invited to stand for election as the [...]

The post Process announced for CPE East and North Midlands Regional Representative election appeared first on Community Pharmacy England.

Community Pharmacy England met in London for a full Committee meeting on 22nd and 23rd April. Despite significant efforts by all parties, negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2026/27 have not yet concluded. Government requirements dictate that negotiations must remain confidential but, as pharmacy owners themselves, Committee Members know [...]

The post Latest 2026/27 CPCF negotiations position scrutinised at April meeting appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Budesonide 3mg gastro-resistant modified-release capsules Tillotts Pharma UK Ltd 100 capsules Complete pack Deferiprone [...]

The post 6 products re-classified as special containers from May 2026 appeared first on Community Pharmacy England.